The pricing would be inside the $20.00-$23.00 target range.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on JNJ:
- Johnson and Johnson IPO Today – Consumer Healthcare Unit Starts Trading at $22
- J&J’s Janssen reports 72.7% complete response rate in bladder cancer study
- J&J’s Kenvue spinoff a rare IPO winner in moribund market, Barron’s says
- Johnson & Johnson’s Kenvue targeted by talcum powder cancer claims, FT reports
- Alkermes arbitration award better than expected, says Mizuho